Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

52.21
-4.0600-7.22%
Post-market: 51.50-0.7100-1.36%19:55 EDT
Volume:1.18M
Turnover:62.55M
Market Cap:1.55B
PE:-19.42
High:56.29
Open:56.27
Low:51.84
Close:56.27
52wk High:170.87
52wk Low:32.21
Shares:29.68M
Float Shares:21.23M
Volume Ratio:0.98
T/O Rate:5.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6887
EPS(LYR):-0.7339
ROE:-30.42%
ROA:-4.37%
PB:6.10
PE(LYR):-71.14

Loading ...

GeneDx Falls Premarket After Company Slashes '26 Rev View

Dow Jones
·
May 05

GeneDx Shares Slump 41.5% Premarket to $39.71 After Co Trims FY REV Outlook

THOMSON REUTERS
·
May 05

Stock Track | GeneDx Holdings Plunges 40% in Pre-Market After Q1 Revenue Miss and Drastic Full-Year Guidance Cut

Stock Track
·
May 05

U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi

Reuters
·
May 05

Stock Track | GeneDx Holdings Plunges 42.96% After-Hours on Q1 Revenue Miss and Drastic Full-Year Guidance Cut

Stock Track
·
May 05

GeneDx Holdings Corp : Canaccord Genuity Cuts Target Price to $75 From $100

THOMSON REUTERS
·
May 05

GeneDx Holdings Corp : Jefferies Cuts Target Price to $100 From $150

THOMSON REUTERS
·
May 05

GeneDx Holdings Corp : Guggenheim Cuts Target Price to $70 From $100

THOMSON REUTERS
·
May 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GeneDx Holdings (WGS) and Crispr Therapeutics AG (CRSP)

TIPRANKS
·
May 05

Stock Track | GeneDx Holdings Plunges 40.22% in Post-Market Trading After Q1 Revenue Miss and Drastic Full-Year Guidance Cut

Stock Track
·
May 05

GUIDANCE: (WGS) GeneDx Now Expects Full Year 2026 Revenue Range $475M - $490M, vs. FactSet Est of $550M

MT Newswires Live
·
May 05

Earnings Flash (WGS) GeneDx Posts Q1 Revenue $102.3M, vs. FactSet Est of $112.5M

MT Newswires Live
·
May 05

BUZZ-GeneDx plunges after trimming annual revenue forecast

Reuters
·
May 05

Stock Track | GeneDx Holdings Plunges 45.53% After-Hours on Q1 Revenue Miss and Drastic FY26 Guidance Cut

Stock Track
·
May 05

GeneDx reports Q1 adjusted loss ($8.2M) vs. ($9.2M) last year

TIPRANKS
·
May 05

GeneDx Q1 FY26 adjusted net loss widens to $8.2 million; revenue rises 17% to $102.3 million

Reuters
·
May 05

GeneDx Hldgs Q1 Adj. EPS $0.31 Beats $(0.01) Estimate, Sales $102.300M Miss $112.956M Estimate

Benzinga
·
May 05

BRIEF-GeneDx Q1 Revenue USD 102.3 Million Vs. IBES Estimate USD 113 Million

Reuters
·
May 05

GeneDx Holdings Corp FY2026 REV View $550.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
May 05

GeneDx Holdings Corp Outlook Q2 REV $110 Mln to $112 Million

THOMSON REUTERS
·
May 05